Document is current

Any future updates will be listed below

13. Lixisenatide as add-on treatment among patients with different beta-cell function levels as assessed by HOMA-beta index (1018-P)

Crossref DOI link: https://doi.org/10.1007/s12467-014-0038-x

Published Online: 2014-11-25

Published Print: 2014-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark